UCLA researchers in the Departments of Chemistry, Physics, and Bioengineering, led by Dr. Tim Deming of the Bioengineering Department, have developed new methods for adding different functional groups on polypeptides. The UCLA researchers have used this method to create a platform to create and modify nanoscale vesicles and hydrogels for use in nanoscale drug delivery particles, injectable drug depots, imaging and detection, industrial biomaterials, and wound management.
Overview: Functionalized polypeptides and proteins are useful as drug delivery vehicles, composites and novel ligands. However, synthesis of complex polypeptides with defined modifications is a challenging task as functional side chains require complex and expensive methods to install. Additionally, current methods often introduce undesirable linkages or unnatural components that may affect use.
Platform to Create and Modify Nanoscale Drug Delivery Materials: With the rise of healthcare costs, the global pharmaceutical and biopharmaceutical industries have begun investing in alternative drug delivery technologies. In an effort to identify new and additional treatments, biologics and large molecules are becoming more important to pharmaceutical companies. For this reason, nanotechnology-enabled drug delivery mechanisms have received significant research and development over the past few years. These nanoscale systems offer the promise of minimizing toxicity, maximizing bioavailability, allowing for precise drug delivery, and controlled release of the payload.
Platform to Create and Modify Nanoscale Vesicles and Hydrogels for Use in Imaging and Detection: Biologic imaging is a key method for detection and analysis within the medical, pharmaceutical, and biotechnology industries. Core to the biologic imaging industry leaders’ competitive strategy relies on acquiring unique imaging reagents based on nanotechnology. For this reason, nanotechnology-based imaging reagents have received significant research and development over the past few years. These nanoscale systems are promising for diagnostic applications including disease detection, augmentation of gold standard methods, and addressing the demand of a molecular approach toward personalized disease monitoring.
Platform to Create and Modify Nanoscale Particles and Gels for Use in the Industrial Biomaterials Market: Advanced materials play a critical role within a variety of industries across the globe. From construction, utilities, transportation and logistics, food and beverage, cosmetics, telecommunications, electronics, oil and gas, petrochemicals, and packaging, industries are heavily investing in advanced materials to address their needs. For this reason, nanoscale technologies have received significant research and development over the past few years. These nanoscale systems offer the promise of stability, synthetic, reproducible, and low cost.
Platform to Create and Modify Nanoscale Vesicles and Hydrogels for Use in Wound Management: With the increasing elderly population, the wound management market has been greatly affected, primarily due to the increase incidents of skin ulcers and surgical procedures. The wound management market has begun investing heavily in advanced dressing technologies as a means to address the rise in healthcare costs. These advanced dressing technologies include materials to deliver cells to the wound site; materials to deliver proteins, such as collagen, to the wound; and materials to act as artificial skin or as skin replacement. Many of these advanced materials are based on nanoscale gels and vesicles as a means to adhere to the wound at the cellular level.These nanoscale systems offer the promise of minimizing toxicity, maximizing bioavailability, and potentially reducing scarring.
UCLA researchers in the Departments of Chemistry, Physics, and Bioengineering, led by Dr. Tim Deming of the Bioengineering Department, have developed a new method for adding different functional groups on polypeptides. Their approach is a simple one step addition of a wide range of functional modifications generating novel polypeptides. Their method utilizes stable thioether linkages on methionine residues by addition of epoxides in mild conditions followed by demethylation all in wet protic media. The process is highly efficient and yields of > 97% for conjugations were obtained. This new approach offers a cost-effective method for synthesizing functionalized polypeptides. This method has numerous applications, as discussed below.
The UCLA researchers have used this method to create a platform to create and modify nanoscale vesicles and hydrogels for use in nanoscale drug delivery particles, injectable drug depots, imaging and detection, industrial biomaterials, and wound management. The polypeptide-based platforms created by the Deming group are customizable in nearly all physical characteristics, can be tailored in size, be loaded with hydrophobic and hydrophilic payloads, adaptable to specific delivery locations, low toxicity, are fully synthetic, possess highly reproducible properties, and are inexpensive to prepare compared to solid-phase peptide synthesis. The platform can be used to create novel, need-based nanoscale vesicles or injectable hydrogels, and can also be used to augment existing nanoparticles.
|United States Of America||Published Application||20150057433||02/26/2015||2012-598|
|European Patent Office||Published Application||EP2831090A||02/04/2015||2012-598|
drug delivery vehicle, cargo, polypeptide vesicles, polymer, nanotechnology/nanomaterial, cell-permeable, synthetic, gels